Fundraising Fox

StimuSIL

Wilmington, US · Founded 2021 · Delaware corporation · 1 known investors

stimusil.com ↗
Biotech

Founders & leadership

AV
Ana Villalba VillarExecutive Officer, Director
PV
Pablo VillalbaExecutive Officer, Director
FY
Firat YerlikayaDirector
AG
Abidin GulmusDirector

Investors · 1

Capital CellBarcelona

Reported raises · per SEC filings

Form D private placements
▶$600KraisedMar 2025 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Abidin GulmusDirector
  • Ana Villalba VillarExecutive Officer, Director
  • Pablo VillalbaExecutive Officer, Director
Offering amount
$600K
Amount sold
$600K
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMay 2024 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Firat YerlikayaDirector
  • Pablo VillalbaExecutive Officer, Director
  • Ana Villalba VillarExecutive Officer, Director
Offering amount
$1.1M
Amount sold
$1.1M
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$48.8KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pablo VillalbaExecutive Officer, Director
  • Firat YerlikayaDirector
  • Ana Villalba VillarExecutive Officer, Director
Offering amount
$48.8K
Amount sold
$48.8K
First sale
Aug 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$575KraisedAug 2022 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pablo VillalbaExecutive Officer, Director
  • Ana Villalba VillarExecutive Officer, Director
  • Firat YerlikayaDirector
Offering amount
$575K
Amount sold
$575K
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.